Triglycerides and cardiovascular risk

K. E. L. Harchaoui; M. E. Visser; J. J. P. Kastelein; E. S. Stroes; G. M. Dallinga-Thie

doi:https://doi.org/10.2174/157340309788970315

Triglycerides and cardiovascular risk

K. E. L. Harchaoui, M. E. Visser, J. J. P. Kastelein, E. S. Stroes, G. M. Dallinga-Thie

Research output: Contribution to journal › Article › Academic › peer-review

117 Citations (Scopus)

Abstract

In 1996 a meta-analysis was published showing that an increase in plasma triglyceride (TG) levels was associated with an increase in CHD risk, even after adjustment for high density lipoprotein cholesterol (HDL-C) levels. Very recently, two studies were published that further extent the early observation and showed the importance of nonfasting plasma triglyceride (TG) levels in the prediction of risk on coronary heart disease (CHD). In the current review we have summarized all available evidence obtained in clinical studies showing that treatment guidelines should reconsider to include nonfasting TG in their risk assessments as nonfasting TG levels may better predict CVD risk

Original language	English
Pages (from-to)	216-222
Journal	Current Cardiology Reviews
Volume	5
Issue number	3
DOIs	https://doi.org/10.2174/157340309788970315
Publication status	Published - 2009

Access to Document

https://doi.org/10.2174/157340309788970315

Cite this

@article{342256f32c6b4866bb591141c37f5e0f,

title = "Triglycerides and cardiovascular risk",

abstract = "In 1996 a meta-analysis was published showing that an increase in plasma triglyceride (TG) levels was associated with an increase in CHD risk, even after adjustment for high density lipoprotein cholesterol (HDL-C) levels. Very recently, two studies were published that further extent the early observation and showed the importance of nonfasting plasma triglyceride (TG) levels in the prediction of risk on coronary heart disease (CHD). In the current review we have summarized all available evidence obtained in clinical studies showing that treatment guidelines should reconsider to include nonfasting TG in their risk assessments as nonfasting TG levels may better predict CVD risk",

author = "Harchaoui, {K. E. L.} and Visser, {M. E.} and Kastelein, {J. J. P.} and Stroes, {E. S.} and Dallinga-Thie, {G. M.}",

year = "2009",

doi = "https://doi.org/10.2174/157340309788970315",

language = "English",

volume = "5",

pages = "216--222",

journal = "Current Cardiology Reviews",

issn = "1875-6557",

publisher = "Bentham Science Publishers B.V.",

number = "3",

}

TY - JOUR

T1 - Triglycerides and cardiovascular risk

AU - Harchaoui, K. E. L.

AU - Visser, M. E.

AU - Kastelein, J. J. P.

AU - Stroes, E. S.

AU - Dallinga-Thie, G. M.

PY - 2009

Y1 - 2009

N2 - In 1996 a meta-analysis was published showing that an increase in plasma triglyceride (TG) levels was associated with an increase in CHD risk, even after adjustment for high density lipoprotein cholesterol (HDL-C) levels. Very recently, two studies were published that further extent the early observation and showed the importance of nonfasting plasma triglyceride (TG) levels in the prediction of risk on coronary heart disease (CHD). In the current review we have summarized all available evidence obtained in clinical studies showing that treatment guidelines should reconsider to include nonfasting TG in their risk assessments as nonfasting TG levels may better predict CVD risk

AB - In 1996 a meta-analysis was published showing that an increase in plasma triglyceride (TG) levels was associated with an increase in CHD risk, even after adjustment for high density lipoprotein cholesterol (HDL-C) levels. Very recently, two studies were published that further extent the early observation and showed the importance of nonfasting plasma triglyceride (TG) levels in the prediction of risk on coronary heart disease (CHD). In the current review we have summarized all available evidence obtained in clinical studies showing that treatment guidelines should reconsider to include nonfasting TG in their risk assessments as nonfasting TG levels may better predict CVD risk

U2 - https://doi.org/10.2174/157340309788970315

DO - https://doi.org/10.2174/157340309788970315

M3 - Article

C2 - 20676280

SN - 1875-6557

VL - 5

SP - 216

EP - 222

JO - Current Cardiology Reviews

JF - Current Cardiology Reviews

IS - 3

ER -